Structure via PubChem · Public domain (PubChem)
cyclopentobarbital
Sign in to saveAlso known as cyclopal
Cyclopentobarbital sodium (Cyclopal, Dormisan) is a barbiturate derivative invented in the 1940s. It has sedative and anticonvulsant properties, and was used primarily as an anaesthetic in veterinary medicine. Cyclopal is considered similar in effects to phenobarbital but lasts almost three times as long, and is considered a long-acting barbiturate with a fairly slow onset of action.
In the Vinony graph
Within Vinony's link graph, cyclopentobarbital is referenced by 494 other articles, and connects out to benzodiazepine drug, alphenal and inhalational anaesthetic.
It is catalogued under topics including Allyl compounds, Barbiturates and Chemical pages without DrugBank identifier.
Its subject is documented across 6 Wikipedia language editions.
Chemical data
- Formula
- C12H14N2O3
- Molecular weight
- 234.25 g/mol
- IUPAC name
- 5-cyclopent-2-en-1-yl-5-prop-2-enyl-1,3-diazinane-2,4,6-trione
- SMILES
- C=CCC1(C(=O)NC(=O)NC1=O)C2CCC=C2
- InChIKey
- XOVJAYNMQDTIJD-UHFFFAOYSA-N
- XLogP
- 1.3
- Polar surface area
- 75.3 Ų
- H-bond donors
- 2
- H-bond acceptors
- 3
- Formal charge
- 0
via PubChem
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 234.1
Show 4 more facts
- Commons category
- Cyclopentobarbital
- chemical formula
- C₁₂H₁₄N₂O₃
- canonical SMILES
- C=CCC1(C(=O)NC(=O)NC1=O)C2CCC=C2
- has characteristic
- bitterness
Sources (2)
via Wikidata · CC0
~1 min read
Encyclopedic overview
2 sectionsContents
- See also
- References
Cyclopentobarbital sodium (Cyclopal, Dormisan) is a barbiturate derivative invented in the 1940s. It has sedative and anticonvulsant properties, and was used primarily as an anaesthetic in veterinary medicine. Cyclopal is considered similar in effects to phenobarbital but lasts almost three times as long, and is considered a long-acting barbiturate with a fairly slow onset of action.
== See also == Barbiturate
Excerpted from Wikipedia’s “cyclopentobarbital” article, available under the CC BY-SA 4.0 licence.